European Archives - Page 299 of 1005 - European Medical Journal

EMJ Urology 11.1 2023 feature image

SuPARnostic: An Advanced Predictive Tool for Detecting Recurrence in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most common malignant kidney tumour, with clear cell RCC (ccRCC) accounting for 70–80% of all cases. Approximately 15–20% of patients have primary metastatic RCC at diagnosis, and 15–20% of those who receive curative treatment for localised tumours will experience recurrence within 5 years of follow-up.

EMJ Urology 11.1 2023 feature image

Genomic Profiling of Urothelial Carcinoma in Situ of the Bladder

Urothelial carcinoma in situ (CIS) of the bladder is an intra-epithelial, high grade, malignant neoplasm characterised by flat (non-papillary) growth, with high probability of disease progression.

5 minutes with Emma Chaffin, former Vice President, Country Head and Site Lead, Galapagos

Pharma leader Emma Chaffin talks about leaving pharmacy for the pharma and a key challenge facing her function.

Getting to the heart of synthetic data

Synthetic data can streamline clinical trials and enable ideas to be tested without draining R&D budgets. Read more about pros and cons of this approach.

Spotlight: January-April 2023

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering landmark therapy approvals, insulin price cuts and much more.

Interview: Nancy Reau

My father always wanted me to be a doctor. He was a police officer and would come home late at night, talking about forensics and autopsies. My best friend in grade school had doctors for parents: a neurologist and neurosurgeon.

Unlocking pharma's creative juices

Explore the benefits of using agencies in pharma marketing and some of the reasons why creativity needs to be brought to the foreground.

Fighting Inequality: Pioneering Research in Endometriosis

This episode focuses on endometriosis and discusses current and new innovative ways for diagnosing this condition.

Interview: Thomas Huizinga

Since I was in high school I have always found these topics very interesting. But I was also very interested in pathogenesis and wanted to know how biology works.

Interview: Katherine P. (Kathy) Andriole

Through my engineering work, I was particularly interested in signal processing, and signals in computers are really just ones and zeros that you can manipulate mathematically.